Found: 24
Select item for more details and to access through your institution.
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 325, doi. 10.1007/s10549-018-4828-5
- By:
- Publication type:
- Article
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08082-x
- By:
- Publication type:
- Article
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08082-x
- By:
- Publication type:
- Article
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08082-x
- By:
- Publication type:
- Article
Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 2, p. 833, doi. 10.1007/s00520-020-05543-5
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 1, p. 387, doi. 10.1007/s00520-020-05473-2
- By:
- Publication type:
- Article
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).
- Published in:
- 2018
- By:
- Publication type:
- journal article
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).
- Published in:
- 2016
- By:
- Publication type:
- journal article
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920910913
- By:
- Publication type:
- Article
The Granulin-Epithelin Precursor Is a Steroid-Regulated Growth Factor in Endometrical Cancer.
- Published in:
- Reproductive Sciences, 2006, v. 13, n. 4, p. 304, doi. 10.1016/j.jsgi.2006.03.003
- By:
- Publication type:
- Article
Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma.
- Published in:
- Diagnostics (2075-4418), 2013, v. 3, n. 1, p. 13, doi. 10.3390/diagnostics3010013
- By:
- Publication type:
- Article
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2537, doi. 10.1002/cncr.29327
- By:
- Publication type:
- Article
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2675, doi. 10.1002/cncr.28130
- By:
- Publication type:
- Article
Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e284, doi. 10.1634/theoncologist.2018-0803
- By:
- Publication type:
- Article
Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 617, doi. 10.1634/theoncologist.2018-0298
- By:
- Publication type:
- Article
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1016, doi. 10.1634/theoncologist.2018-0033
- By:
- Publication type:
- Article
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 750, doi. 10.1002/cncr.35078
- By:
- Publication type:
- Article
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
- Published in:
- Journal of the American Geriatrics Society, 2019, v. 67, n. 5, p. 920, doi. 10.1111/jgs.15493
- By:
- Publication type:
- Article